Eton Pharmaceuticals ($ETON) Insider Trading & Smart Money Activity
Eton Pharmaceuticals, Inc. ($ETON) has 6 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($229.41K), net -$229.41K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$229.41K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
ETON insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $229.41K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ETON insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Krempa DavidChief Business Officer | Sell (Open-market sale) | 4.17K sh | $229.41K | -2.6% | — | |||||
| Insider | David KrempaChief Business Officer | Buy (Grant or award) | 10K sh | +6.5% | +18.5% | Read | |||||
| Insider | Adams Jennifer Mckie | Sell (Option exercise) | 50K sh | +3.7% | +29.2% | — | |||||
| Insider | Adams Jennifer Mckie | Sell (Option exercise) | 50K sh | +3.7% | +29.2% | Read | |||||
| Insider | Adams Jennifer Mckie | Buy (Option exercise) | 50K sh | $189K | +3.7% | +29.2% | — | ||||
| Insider | Adams Jennifer Mckie | Buy (Option exercise) | 50K sh | $189K | +3.7% | +29.2% | Read |
1W / 1M / 6M = how ETON moved from the trade or filing date.
Insider trading in ETON: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Krempa David | Chief Business Officer | 1 | -$229.41K | Oct 6, 2026 | |
| David Krempa | Chief Business Officer | 1 | — | Jun 26, 2026 | |
| Adams Jennifer Mckie | 4 | — | Jun 17, 2026 |
Frequently asked questions
Are ETON insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $229.41K, a net -$229.41K.
What is the latest insider trade in ETON?
Krempa David, Chief Business Officer filed a sell (open-market sale) of 4.17K sh worth $229.41K on Oct 6, 2026.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.